XtalPi Funding & Investors
Cambridge, MA
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.
http://www.xtalpi.com/Total Amount Raised:
XtalPi Funding Rounds
Series D
$400,000,000
Series D Investors
HOPU InvestmentOrbiMed AdvisorsSino Biopharmaceutical5Y CapitalSequoia Capital ChinaTaihill VentureSeries C
$318,800,000
Series C Investors
5Y CapitalPICC Asset Management Co.SoftBank Vision FundSIG China (SIG Asia Investments)TencentChina Life Healthcare FundSequoia Capital ChinaIMO VenturesCITIC Capital HoldingsCMB International's Telecom Fund.Oceanpine CapitalShunwei CapitalMirae AssetMorningside CapitalSeries B
$46,000,000
Series B Investors
China Life Healthcare FundYael CapitalSIG China (SIG Asia Investments)HT CapitalSeries B
$15,000,000
Series B Investors
Sequoia Capital ChinaAlphabetTencentSeries A
60,751 CNY
Series A Investors
ZhenFundSeries A
1,231,952 CNY
Series A Investors
Frees FundZhenFundSeries A
$5,000,000
Series A Investors
TencentFrees FundZhenFundAngel
$309,000
Angel Investors
Renren